{"id":"https://openalex.org/W7204989939","doi":"https://doi.org/10.1111/dom.71262","title":"Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts","display_name":"Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7204989939","doi":"https://doi.org/10.1111/dom.71262","pmid":"https://pubmed.ncbi.nlm.nih.gov/42681821","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13646362"},"language":"en","primary_location":{"id":"doi:10.1111/dom.71262","doi":"https://doi.org/10.1111/dom.71262","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71262","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71262","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71262","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071620913","display_name":"Shilpa Garg","orcid":"https://orcid.org/0009-0004-5086-4744","observed_orcids":["https://orcid.org/0009-0004-5086-4744"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"S. Garg","raw_affiliation_strings":["Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK"],"raw_orcid":"https://orcid.org/0009-0004-5086-4744","affiliations":[{"raw_affiliation_string":"Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149014020","display_name":"R. Kitchen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kitchen","raw_affiliation_strings":["Novo Nordisk Research Centre Oxford  Oxford UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Research Centre Oxford  Oxford UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Gupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Gupta","raw_affiliation_strings":["Novo Nordisk Research Centre Oxford  Oxford UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Research Centre Oxford  Oxford UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082891416","display_name":"Louise A. Donnelly","orcid":"https://orcid.org/0000-0003-4902-1040","observed_orcids":["https://orcid.org/0000-0003-4902-1040"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Donnelly","raw_affiliation_strings":["Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK"],"raw_orcid":"https://orcid.org/0000-0003-4902-1040","affiliations":[{"raw_affiliation_string":"Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087774397","display_name":"Ewan R. Pearson","orcid":"https://orcid.org/0000-0001-9237-8585","observed_orcids":["https://orcid.org/0000-0001-9237-8585"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. R. Pearson","raw_affiliation_strings":["Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Endocrinology and Reproductive Biology University of Dundee  Dundee UK","institution_ids":["https://openalex.org/I177639307"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071620913"],"corresponding_institution_ids":["https://openalex.org/I177639307"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.64029833,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"11","first_page":"10780","last_page":"10794"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.2296999990940094,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.14010000228881836,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-response-variability","display_name":"drug response variability","score":0.6600000262260437},{"id":"https://openalex.org/keywords/polygenic-risk-score","display_name":"polygenic risk score","score":0.7739999890327454},{"id":"https://openalex.org/keywords/glycemic-response","display_name":"glycemic response","score":0.828000009059906},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8399999737739563},{"id":"https://openalex.org/keywords/glucose-lowering-therapy","display_name":"glucose-lowering therapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8880000114440918},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9980000257492065},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/genetic-factors","display_name":"genetic factors","score":0.4790000021457672},{"id":"https://openalex.org/keywords/clinical-determinants","display_name":"clinical determinants","score":0.6589999794960022},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8658000230789185},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.8125},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6431999802589417},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6114000082015991},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4984000027179718},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4803999960422516},{"id":"https://openalex.org/C2994119904","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Drug response","level":3,"score":0.4546999931335449},{"id":"https://openalex.org/C68873052","wikidata":"https://www.wikidata.org/wiki/Q349856","display_name":"Genetic variation","level":3,"score":0.44530001282691956},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.41929998993873596},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.400299996137619},{"id":"https://openalex.org/C67636389","wikidata":"https://www.wikidata.org/wiki/Q784237","display_name":"Genetic predisposition","level":3,"score":0.39750000834465027},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.39329999685287476},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.3921000063419342},{"id":"https://openalex.org/C75069973","wikidata":"https://www.wikidata.org/wiki/Q913584","display_name":"Genetic genealogy","level":3,"score":0.3752000033855438},{"id":"https://openalex.org/C177860879","wikidata":"https://www.wikidata.org/wiki/Q5532897","display_name":"Genetic epidemiology","level":3,"score":0.3610999882221222},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.3497999906539917},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.34880000352859497},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3474999964237213},{"id":"https://openalex.org/C106208931","wikidata":"https://www.wikidata.org/wiki/Q1098876","display_name":"Genome-wide association study","level":5,"score":0.34470000863075256},{"id":"https://openalex.org/C186413461","wikidata":"https://www.wikidata.org/wiki/Q744727","display_name":"Genetic association","level":5,"score":0.3264000117778778},{"id":"https://openalex.org/C3018380654","wikidata":"https://www.wikidata.org/wiki/Q5572348","display_name":"Fasting glucose","level":4,"score":0.3249000012874603},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.3107999861240387},{"id":"https://openalex.org/C169594400","wikidata":"https://www.wikidata.org/wiki/Q244775","display_name":"Twin study","level":3,"score":0.3046000003814697},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.29840001463890076},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29840001463890076},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.2913999855518341},{"id":"https://openalex.org/C2993967602","wikidata":"https://www.wikidata.org/wiki/Q5532932","display_name":"Genetic variants","level":4,"score":0.2881999909877777},{"id":"https://openalex.org/C130947863","wikidata":"https://www.wikidata.org/wiki/Q5533121","display_name":"Gene\u2013environment interaction","level":4,"score":0.2847999930381775},{"id":"https://openalex.org/C2992519594","wikidata":"https://www.wikidata.org/wiki/Q870433","display_name":"Genetic model","level":3,"score":0.28380000591278076},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.28349998593330383},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.28119999170303345},{"id":"https://openalex.org/C2910466267","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug-drug interaction","level":3,"score":0.28029999136924744},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2759000062942505},{"id":"https://openalex.org/C2779318504","wikidata":"https://www.wikidata.org/wiki/Q1438035","display_name":"Research design","level":2,"score":0.27070000767707825},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2621999979019165},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.26030001044273376},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25760000944137573},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.2572000026702881}],"mesh":[{"descriptor_ui":"D000092005","descriptor_name":"Insulin Secretagogues","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000092126","descriptor_name":"PPAR-gamma Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000096442","descriptor_name":"Genetic Risk Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000096962","descriptor_name":"Treatment Effect Heterogeneity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000097849","descriptor_name":"UK Biobank","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012606","descriptor_name":"Scotland","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018070","descriptor_name":"Biological Specimen Banks","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/dom.71262","doi":"https://doi.org/10.1111/dom.71262","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71262","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71262","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"doi:10.2139/ssrn.6786056","doi":"https://doi.org/10.2139/ssrn.6786056","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.6786056","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:42681821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42681821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/455f74c0-7f1f-4a81-9014-82a9229a78e2","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/455f74c0-7f1f-4a81-9014-82a9229a78e2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Garg, S, Kitchen, R, Gupta, R, Donnelly, L & Pearson, E R 2026, 'Genetic and clinical determinants of variation in drug response in type 2 diabetes : Insights from the Scottish and UK biobank cohorts', Diabetes, Obesity & Metabolism, vol. 28, no. 11, pp. 10780-10794. https://doi.org/10.1111/dom.71262","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13646362","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13646362/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/dom.71262","doi":"https://doi.org/10.1111/dom.71262","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71262","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71262","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310838","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204989939.pdf","grobid_xml":"https://content.openalex.org/works/W7204989939.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W2019409570","https://openalex.org/W2023810596","https://openalex.org/W2025859849","https://openalex.org/W2082704080","https://openalex.org/W2099394962","https://openalex.org/W2103588996","https://openalex.org/W2109887283","https://openalex.org/W2115098571","https://openalex.org/W2124088457","https://openalex.org/W2140964565","https://openalex.org/W2147804662","https://openalex.org/W2157115201","https://openalex.org/W2162590815","https://openalex.org/W2409903382","https://openalex.org/W2412511061","https://openalex.org/W2492672367","https://openalex.org/W2625625371","https://openalex.org/W2740953649","https://openalex.org/W2749667694","https://openalex.org/W2752050463","https://openalex.org/W2783375883","https://openalex.org/W2790917829","https://openalex.org/W2804386169","https://openalex.org/W2902225118","https://openalex.org/W2948262697","https://openalex.org/W3017637887","https://openalex.org/W3045441625","https://openalex.org/W3094373713","https://openalex.org/W3165284685","https://openalex.org/W3170942141","https://openalex.org/W4220682865","https://openalex.org/W4280552086","https://openalex.org/W4296802076","https://openalex.org/W4304789317","https://openalex.org/W4309648555","https://openalex.org/W4378232900","https://openalex.org/W4389132345","https://openalex.org/W4391925503","https://openalex.org/W4392472036","https://openalex.org/W4404719470","https://openalex.org/W4405995651","https://openalex.org/W4407931197","https://openalex.org/W4413435670","https://openalex.org/W4414274945"],"related_works":["https://openalex.org/W3094373713","https://openalex.org/W4411589572","https://openalex.org/W4317376278","https://openalex.org/W2948961635","https://openalex.org/W7172255262","https://openalex.org/W2474407296","https://openalex.org/W4400831849","https://openalex.org/W6923712774","https://openalex.org/W3203518968","https://openalex.org/W2796240200"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Treatment":[1],"response":[2,37,172,199],"in":[3,35,59,108,305,329],"type":[4],"2":[5],"diabetes":[6,331],"(T2D)":[7],"varies":[8],"widely":[9],"among":[10],"individuals.":[11],"This":[12],"study":[13],"aimed":[14],"to":[15,33,38,200,302,321],"quantify":[16],"the":[17,52,64,106,319],"contributions":[18],"of":[19,54,76,81],"clinical":[20,119,296],"characteristics":[21],"and":[22,57,63,118,127,131,146,155,187,202,215,282,297,317,325],"genetic":[23,96,223,241,298],"predisposition":[24],"as":[25,105],"measured":[26],"through":[27],"partitioned":[28],"polygenic":[29],"risk":[30,224],"scores":[31],"(pPRS)":[32],"variation":[34],"glycemic":[36,171],"glucose-lowering":[39],"therapies.":[40],"RESEARCH":[41],"DESIGN":[42],"AND":[43],"METHOD:":[44],"We":[45],"analysed":[46],"data":[47],"from":[48],"two":[49],"population-based":[50],"cohorts:":[51],"Genetics":[53],"Diabetes":[55],"Audit":[56],"Research":[58],"Tayside":[60],"Scotland":[61],"(GoDARTS)":[62],"UK":[65,216],"Biobank":[66,217],"(UKBB).":[67],"GoDARTS":[68,214],"included":[69,116],"41":[70],"802":[71],"patients":[72],"who":[73],"initiated":[74],"one":[75],"six":[77],"major":[78],"drug":[79,147,247,307],"classes,":[80],"whom":[82],"11":[83],"615":[84],"had":[85],"available":[86],"genotype":[87],"data.":[88,97],"UKBB":[89],"contributed":[90],"9371":[91],"individuals,":[92],"including":[93,249],"8293":[94],"with":[95,170,181,193,197,208,227,231,246,253,263,273,285],"The":[98],"primary":[99],"outcome":[100],"was":[101,166,178,225],"glycaemic":[102,210],"response,":[103],"defined":[104],"change":[107],"HbA1c":[109,165,183,229],"12":[110],"months":[111],"after":[112],"treatment":[113],"initiation.":[114],"Variables":[115],"demographic":[117],"factors":[120,299],"(age,":[121],"sex,":[122],"BMI,":[123],"baseline":[124],"HbA1c,":[125],"kidney":[126],"liver":[128],"function":[129,251],"markers)":[130],"14":[132],"pPRS":[133,284],"representing":[134],"T2D-related":[135],"biological":[136],"pathways.":[137],"Linear":[138],"regression":[139],"models":[140],"were":[141,158,243],"fitted":[142],"within":[143],"each":[144],"cohort":[145],"class":[148],"(metformin,":[149],"sulfonylureas,":[150],"TZDs,":[151],"DPP4i,":[152],"SGLT2i,":[153],"GLP-1RA),":[154],"effect":[156],"estimates":[157],"combined":[159],"using":[160],"fixed-effect":[161],"meta-analysis.":[162],"RESULT:":[163],"Baseline":[164],"most":[167],"strongly":[168],"associated":[169,180,196,207,226,245],"(p":[173],"<":[174],"0.001).":[175],"Older":[176],"age":[177],"consistently":[179],"greater":[182,228],"reduction,":[184],"while":[185],"BMI":[186,195],"total":[188,204],"cholesterol":[189,205],"demonstrated":[190],"drug-class-specific":[191],"associations,":[192],"higher":[194,203,220],"improved":[198],"TZDs":[201],"generally":[206],"poorer":[209],"outcomes.":[211],"Meta-analysis":[212],"across":[213],"showed":[218],"that":[219],"overall":[221],"T2D":[222,306],"reduction":[230],"sulfonylureas":[232,254],"(\u03b2":[233,255,265,276,288],"=":[234,238,256,259,266,269,277,280,289,292],"-0.46":[235],"mmol/mol,":[236],"p":[237,258,268,279,291],"0.013).":[239],"Specific":[240],"profiles":[242],"also":[244],"responses,":[248],"\u03b2-cell":[250],"clusters":[252],"-0.57,":[257],"0.002),":[260],"obesity-related":[261],"variants":[262,272],"GLP-1RA":[264],"-1.49,":[267],"0.04),":[270],"liver-lipid":[271],"SGLT2":[274],"inhibitors":[275,287],"-0.84,":[278],"0.05),":[281],"bilirubin":[283],"DPP-4":[286],"-0.69,":[290],"0.006).":[293],"CONCLUSION:":[294],"Both":[295],"significantly":[300],"contribute":[301],"inter-individual":[303],"variability":[304],"response.":[308],"Partitioned":[309],"PRSs":[310],"provide":[311],"mechanistic":[312],"insights":[313],"into":[314],"drug-specific":[315],"pathways":[316],"have":[318],"potential":[320],"inform":[322],"precision":[323],"prescribing":[324],"optimise":[326],"therapeutic":[327],"outcomes":[328],"routine":[330],"care.":[332]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-09-02T00:00:00"}